scorecardresearch
Tuesday, November 5, 2024
Support Our Journalism
HomeSportDutee Chand tests positive for prohibited substances

Dutee Chand tests positive for prohibited substances

Follow Us :
Text Size:

New Delhi, Jan 18 (PTI) Celebrated Indian sprinter Dutee Chand has tested positive for prohibited anabolic steroids during an out-of-competition testing and has been provisionally suspended.

The urine sample of the 26-year-old, who finished second in both the 100m and 200m events at the 2018 Asian Games and is the reigning national 100m champion, has returned adverse analytical findings (AAF) for ‘andarine’, ‘ostarine’ and ‘ligandrol’, said a doping control notification on adverse analytical findings issued by the National Anti-doping Agency (NADA).

In a letter addressed to Dutee, the AAF notification said, “I do hereby inform you that your sample A was tested at the NDTL (National Dope Testing Laboratory) in accordance with the procedure set out in WADA’s (World Anti-Doping Agency) International Standard of Laboratories and was returned adverse analytical findings as details given below.” The sample was collected out-of-competition on December 5 last year at Bhubaneswar.

The letter also warned Dutee about the potential consequences.

“I do hereby invite you to carefully read the contents of this letter which provides important information as to the potential consequences of the AAF and resulting disciplinary process,” the letter added.

Dutee, when contacted, said she was unaware of the ‘A’ sample testing positive. “I do not know,” she said. PTI KHS/PDS AM AM APA APA

This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

  • Tags

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular